Literature DB >> 15638293

Growth hormone (GH) peaks versus areas under the curve in the diagnosis of adult GH deficiency: analysis of the variables provided by the GHRH + GHRP-6 test.

Hans P F Koppeschaar1, Vera Popovic, Alfonso Leal, Xose L Otero, Elena Torres, Concha Paramo, Dragan Micic, Ricardo V Garcia-Mayor, Alessandro Sartorio, Carlos Dieguez, Felipe F Casanueva.   

Abstract

BACKGROUND: The diagnosis of growth hormone deficiency (GHD) relies on provocative tests of GH reserve. The aim in these tests is to obtain an objective, biochemical-based, measure of gland function, but clinicians and researchers rely on the GH peak, as a surrogate of the 24-hour pituitary secretion. However, on a mathematical basis the area under the secretory curve (AUC) should be more valid for this evaluation.
OBJECTIVES: To validate which variable provided by a provocative test of GH secretion is mathematically more robust for supporting the clinical diagnosis. Adult normal subjects and GHD patients were challenged with the combined stimulus GHRH + GHRP-6. The diagnostic efficacy of the GH peak, and the AUC were compared by the receiver operating characteristic (ROC) curve methodology. PATIENTS AND METHODS: 146 patients with GH deficiency due to organic pituitary disease and 184 healthy subjects were administered GHRH 1 microg/Kg iv, plus GHRP-6 1 microg/Kg iv, and GH was determined. Four variables were studied: (a) the GH peak; (b) the "standard" AUC, (c) the "stimulated" AUC and (d) the basal value, used as internal control.
RESULTS: Under ROC curve analysis, the basal variable was devoid of diagnostic capability, while the other variables performed strikingly well, the ROC curve area for the GH peak was 0.9997; and for the AUC 0.9993, with no statistical differences.
CONCLUSIONS: The variables provided by measuring the GH peak and the area under the curve were similarly effective for diagnosis, although on clinical grounds, the peak was more convenient as needed no calculation. If results for other test were similar the time-honored method of measuring the GH peak could be considered mathematically validated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15638293     DOI: 10.1023/b:pitu.0000044629.10484.40

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  27 in total

1.  Physical activity or food intake prior to testing did not affect the reproducibility of GH secretion elicited by GH releasing hormone plus GH-releasing hexapeptide in normal adult subjects.

Authors:  Vera Popovic; Sandra Pekic; Mirjana Simic; Svetozar Damjanovic; Dragan Micic; Carlos Dieguez; Felipe F Casanueva
Journal:  Clin Endocrinol (Oxf)       Date:  2002-01       Impact factor: 3.478

Review 2.  Diagnosis of growth hormone deficiency in adulthood.

Authors:  F F Casanueva
Journal:  Eur J Endocrinol       Date:  1996-08       Impact factor: 6.664

Review 3.  The diagnosis of growth hormone deficiency in children and adults.

Authors:  S M Shalet; A Toogood; A Rahim; B M Brennan
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

4.  Growth hormone (GH) response to GH-releasing peptide-6 and GH-releasing hormone in normal-weight and overweight patients with non-insulin-dependent diabetes mellitus.

Authors:  D Micić; D Macut; V Popović; A Kendereski; M Sumarac-Dumanović; S Zorić; C Dieguez; F F Casanueva
Journal:  Metabolism       Date:  1999-04       Impact factor: 8.694

5.  The diagnosis of growth hormone deficiency (GHD) in adults.

Authors:  M O Thorner; B A Bengtsson; K Y Ho; K Albertsson-Wikland; J S Christiansen; G Faglia; M Irie; O Isaksson; J O Jörgensen; M Ranke
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

6.  On the actions of the growth hormone-releasing hexapeptide, GHRP.

Authors:  C Y Bowers; A O Sartor; G A Reynolds; T M Badger
Journal:  Endocrinology       Date:  1991-04       Impact factor: 4.736

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  A single growth hormone (GH) determination is sufficient for the diagnosis of GH-deficiency in adult patients using the growth hormone releasing hormone plus growth hormone releasing peptide-6 test.

Authors:  A Leal; M Lage; V Popovic; E Torres; H P F Koppeschaar; C Paramo; D Micic; R V Garcia-Mayor; C Dieguez; F F Casanueva
Journal:  Clin Endocrinol (Oxf)       Date:  2002-09       Impact factor: 3.478

9.  Hypoglycemia: a potent stimulus to secretion of growth hormone.

Authors:  J ROTH; S M GLICK; R S YALOW
Journal:  Science       Date:  1963-05-31       Impact factor: 47.728

10.  Metabolic modulation of the growth hormone-releasing activity of hexarelin in man.

Authors:  M Maccario; E Arvat; M Procopio; L Gianotti; S Grottoli; B P Imbimbo; V Lenaerts; R Deghenghi; F Camanni; E Ghigo
Journal:  Metabolism       Date:  1995-01       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.